Acurx Pharmaceuticals, Inc. (ACXP) reporting calendar
Acurx Pharmaceuticals, Inc. files periodic reports with the SEC as ACXP on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 24 Jul 2026 – 29 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 11 May 2026
- Reports on record
- 20
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open ACXP market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 11 May 2026 | 41 days | 0001104659-26-058631 |
| 10-K | 31 Dec 2025 | 12 Mar 2026 | 71 days | 0001104659-26-027052 |
| 10-Q | 30 Sep 2025 | 12 Nov 2025 | 43 days | 0001104659-25-109698 |
| 10-Q | 30 Jun 2025 | 11 Aug 2025 | 42 days | 0001558370-25-011045 |
| 10-Q | 31 Mar 2025 | 12 May 2025 | 42 days | 0001558370-25-007371 |
| 10-K | 31 Dec 2024 | 17 Mar 2025 | 76 days | 0001558370-25-003117 |
| 10-Q | 30 Sep 2024 | 12 Nov 2024 | 43 days | 0001558370-24-015310 |
| 10-Q | 30 Jun 2024 | 8 Aug 2024 | 39 days | 0001558370-24-011587 |
| 10-Q | 31 Mar 2024 | 14 May 2024 | 44 days | 0001558370-24-008130 |
| 10-K | 31 Dec 2023 | 15 Mar 2024 | 75 days | 0001558370-24-003401 |
| 10-Q | 30 Sep 2023 | 13 Nov 2023 | 44 days | 0001558370-23-018824 |
| 10-Q | 30 Jun 2023 | 11 Aug 2023 | 42 days | 0001558370-23-014645 |
| 10-Q | 31 Mar 2023 | 12 May 2023 | 42 days | 0001558370-23-009495 |
| 10-K | 31 Dec 2022 | 15 Mar 2023 | 74 days | 0001558370-23-003929 |
| 10-Q | 30 Sep 2022 | 10 Nov 2022 | 41 days | 0001558370-22-017408 |
| 10-Q | 30 Jun 2022 | 12 Aug 2022 | 43 days | 0001410578-22-002396 |
| 10-Q | 31 Mar 2022 | 10 May 2022 | 40 days | 0001410578-22-001250 |
| 10-K | 31 Dec 2021 | 16 Mar 2022 | 75 days | 0001410578-22-000399 |
| 10-Q | 30 Sep 2021 | 12 Nov 2021 | 43 days | 0001104659-21-138038 |
| 10-Q | 30 Jun 2021 | 13 Aug 2021 | 44 days | 0001104659-21-105074 |
Source: SEC EDGAR company submissions for CIK 0001736243. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.